Discontinuation report FOSRENOL
Report ID | 228181 |
Drug Identification Number | 02287161 |
Brand name | FOSRENOL |
Common or Proper name | Lanthanum carbonate hydrate chewable tablets |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | LANTHANUM |
Strength(s) | 750MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL ORAL |
Packaging size | 6 Bottles of 15 tablets |
ATC code | V03AE |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2024-07-31 |
Actual discontinuation date | |
Remaining supply date | 2024-07-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Remaining lot expires SEP2025 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-05-16 | French | Compare |
v1 | 2024-05-16 | English | Compare |
Showing 1 to 2 of 2